SkyView Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
SkyView Investment Advisors's GILD Position: Q1 2026 in Review
SkyView Investment Advisors reduced its Gilead Sciences (GILD) stake by 25% in Q1 2026, selling an estimated $273K and leaving 5,942 shares worth $828K. The position accounts for 0.11% of the portfolio, ranked #129.
SkyView Investment Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.72M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- SkyView Investment Advisors held 5,942 shares of Gilead Sciences worth $828K as of Q1 2026.
- SkyView Investment Advisors sold 1,951 Gilead Sciences shares in Q1 2026, an estimated $273K.
- Gilead Sciences made up 0.11% of SkyView Investment Advisors's portfolio in Q1 2026, its #129 holding.
- SkyView Investment Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
- SkyView Investment Advisors's Gilead Sciences position peaked at $1.72M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.